Paul Rothwell chose to accept a request for a prostate cancer examination at the age of 58.
Although he had no symptoms, he had been informed that the conventional PSA blood test was notoriously unreliable.
Nevertheless, he was happy to learn that his reading was 1.5 (below the cutoff of 3, the level that would call for additional testing given his age).
Paul, a semi-retired TV producer from London, took part in the ReImagine study to see if a new 15-minute MRI, the prostate’s equivalent of a mammogram for breast cancer, could detect prostate cancer more accurately than the PSA test.
He was shocked to learn from the findings of his MRI scan in April 2020 that he not only had the disease, but that it was also severe enough to require treatment.
Paul, 62 year old married man with two daughters said, ‘Without the MRI scan I would never have known.’
In March 2021, he had focused therapy on the NHS as a result of the diagnosis.
The two main therapies for prostate cancer, total prostatectomy surgery or radiotherapy, can both be very effective but come with the possibility of side effects like incontinence and impotence.
As opposed to treating the entire prostate, focal therapy is more focused and targets the cancer specifically.
Paul, a semi-retired TV producer from London, took part in the ReImagine study to see if a new 15-minute MRI, the prostate’s equivalent of a mammogram for breast cancer, could detect prostate cancer more accurately than the PSA test.
He was shocked to learn from the findings of his MRI scan in April 2020 that he not only had the disease, but that it was also severe enough to require treatment.
| Read More: Click Here |
